Bell C, Conway E L, Lang W J, Padanyi R
Br J Pharmacol. 1975 Oct;55(2):167-72. doi: 10.1111/j.1476-5381.1975.tb07625.x.
1 Increases in femoral blood flow were produced by intra-arterial injections of dopamine (5-50 mug) in some but not all anaesthetized dogs studied, following treatment with the alpha-adrenoceptor antagonist, phentolamine. 2 The dilator effect of dopamine was not due to inhibition of adrenergic vasomotor tone as it was not affected by pharmacological procedures which completely abolished the activity of vastomotor nerves. 3 Blockade of vascular beta-adrenoceptors using propanolol reduced the flow increases produced by dopamine much less than it did those produced by isoprenaline. 4 Responses to dopamine were significantly depressed by intra-arterial administration of ergometrine (0.5 mg). This dose of ergometrine did not reduce femoral dilator responses to acetylcholine, histamine, isopienaline, bradykinin, or 5-hydroxytryptamine. 5 It is concluded that the femoral vascular bed in the dog contains specific vasodilator receptors for dopamine. Ergometrine appears to be a selective antagonist of dopamine at these receptors.
在一些但并非所有接受研究的麻醉犬中,经α-肾上腺素能受体拮抗剂酚妥拉明处理后,动脉内注射多巴胺(5 - 50微克)可使股血流量增加。
多巴胺的扩张血管作用并非由于抑制肾上腺素能血管运动张力,因为它不受完全消除血管运动神经活动的药理学方法的影响。
使用普萘洛尔阻断血管β-肾上腺素能受体,对多巴胺引起的血流量增加的降低程度远小于对异丙肾上腺素引起的血流量增加的降低程度。
动脉内给予麦角新碱(0.5毫克)可显著抑制对多巴胺的反应。该剂量的麦角新碱并未降低股血管对乙酰胆碱、组胺、异丙肾上腺素、缓激肽或5-羟色胺的扩张反应。
得出结论,犬的股血管床含有多巴胺特异性血管舒张受体。麦角新碱似乎是这些受体上多巴胺的选择性拮抗剂。